Stratos Wealth Partners LTD. Acquires 217 Shares of Danaher Corporation (NYSE:DHR)

Stratos Wealth Partners LTD. increased its position in Danaher Corporation (NYSE:DHR) by 5.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,063 shares of the conglomerate’s stock after buying an additional 217 shares during the period. Stratos Wealth Partners LTD.’s holdings in Danaher Corporation were worth $348,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in DHR. Peddock Capital Advisors LLC raised its position in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares during the last quarter. ClariVest Asset Management LLC acquired a new position in Danaher Corporation during the first quarter worth $157,000. Motco raised its position in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares during the last quarter. Baystate Wealth Management LLC raised its position in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares during the last quarter. Finally, Integrated Investment Consultants LLC raised its position in Danaher Corporation by 22.1% in the first quarter. Integrated Investment Consultants LLC now owns 2,168 shares of the conglomerate’s stock worth $185,000 after buying an additional 393 shares during the last quarter. 76.12% of the stock is owned by institutional investors and hedge funds.

Shares of Danaher Corporation (NYSE:DHR) traded down 0.05% during midday trading on Friday, reaching $80.87. 2,861,306 shares of the company traded hands. The stock has a market capitalization of $56.18 billion, a price-to-earnings ratio of 25.81 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The company’s 50 day moving average is $82.32 and its 200-day moving average is $84.22.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.90 earnings per share. Equities research analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Stratos Wealth Partners LTD. Acquires 217 Shares of Danaher Corporation (NYSE:DHR)” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.com-unik.info/2017/08/19/stratos-wealth-partners-ltd-increases-position-in-danaher-corporation-nysedhr-updated-updated-updated.html.

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company assumed coverage on shares of Danaher Corporation in a research report on Thursday, July 13th. They set a “market perform” rating and a $90.00 price target on the stock. Jefferies Group LLC restated a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, BTIG Research reiterated a “buy” rating and issued a $92.00 target price on shares of Danaher Corporation in a report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $91.76.

In related news, insider William King sold 7,458 shares of Danaher Corporation stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares in the company, valued at $1,513,787.65. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the sale, the senior vice president now owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold 38,623 shares of company stock worth $3,206,426 in the last quarter. Insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit